InvestorsObserver
×
News Home

Is Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) a Leader in the Medical Devices Industry?

Monday, November 29, 2021 03:45 PM | InvestorsObserver Analysts

Mentioned in this article

Is Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) a Leader in the Medical Devices Industry?

The 54 rating InvestorsObserver gives to Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock puts it near the top of the Medical Devices industry. In addition to scoring higher than 80 percent of stocks in the Medical Devices industry, BIO’s 54 overall rating means the stock scores better than 54 percent of all stocks.

Overall Score - 54
BIO has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on BIO!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Bio-Rad Laboratories, Inc. Class A Common Stock Stock Today?

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock has fallen -1.82% while the S&P 500 has risen 1.51% as of 3:23 PM on Monday, Nov 29. BIO is lower by -$13.93 from the previous closing price of $765.56 on volume of 49,319 shares. Over the past year the S&P 500 has gained 28.78% while BIO has risen 39.58%. BIO earned $220.42 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 3.42. Click Here to get the full Stock Report for Bio-Rad Laboratories, Inc. Class A Common Stock stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App